A clinical spectrum of symptoms and disease progression is seen with alpha-mannosidosis, ranging from mild to severe [2], with severity impacted in part by level of residual alpha-mannosidase activity [7] and subcellular localization of mutant MAN2B1 protein [8]. The gene discussed is MAN2B1; the disease is alpha-mannosidosis.